Abstract
Malignant pleural mesothelioma (MPM) is an aggressive tumour whose main aetiology is the long-term exposure to asbestos fibres. The diagnostic procedure of MPM is difficult and often requires invasive approaches; therefore, it is clinically important to find accurate markers for MPM by new noninvasive methods that may facilitate the diagnostic process and identify patients at an earlier stage. In the present study, the exhaled breath of 13 patients with histology-established diagnosis of MPM, 13 subjects with long-term certified professional exposure to asbestos (EXP) and 13 healthy subjects without exposure to asbestos (healthy controls, HC) were analysed. An analytical procedure to determine volatile organic compounds by sampling of air on a bed of solid sorbent and thermal desorption GC-MS analysis was developed in order to identify the compounds capable of discriminating among the three groups. The application of univariate (ANOVA) and multivariate statistical treatments (PCA, DFA and CP-ANN) showed that cyclopentane and cyclohexane were the dominant variables able to discriminate among the three groups. In particular, it was found that cyclohexane is the only compound able to differentiate the MPM group from the other two; therefore, it can be a possible marker of MPM. Cyclopentane is the dominant compound in the discrimination between EXP and the other groups (MPM and HC); then, it can be considered a good indicator for long-term asbestos exposure. This result suggests the need to perform frequent and thorough investigations on people exposed to asbestos in order to constantly monitor their state of health or possibly to study the evolution of disease over time.
Similar content being viewed by others
References
Robinson BW, Lake RA (2005) Advances in previous malignant mesothelioma. N Engl J Med 353(15):1591–1603
Curran D, Sahmoud T, Therasse P, van Meerbeeck J, Postmus PE, Giaccone G (1998) Prognostic factors in patients with previous pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol 16(1):145–152
Grellier L, Astoul P (2008) Mesothelioma and asbestos-related plueral diseases. Respiration 76:1–15
Kaufman AJ, Pass HI (2008) Current concepts in malignant pleural mesothelioma. Expert Rev Anticancer Ther 8:293–303
Kent M, Rice D, Flores R (2008) Diagnosis, staging and surgical treatment of malignant pleural mesothelioma. Curr Treat Options Oncol 9:158–170
Greillier L, Baas P, Welch JJ, Hasan B, Passioukov A (2008) Biomarkers for malignant pleural mesothelioma. Mol Diagn Ther 12:375–390
Pauling L, Robinson AB, Teranishi R, Cary P (1971) Quantitative analysis of urine vapour and breath by gas–liquid partition chromatography. Proc Nat Acad Sci 68:2374–2376
Rooth G, Ostenson S (1966) Acetone in alveolar air and the control of diabetes. Lancet 2:1102–1105
Gordon SM, Szidon JP, Krotoszynski BK, Gibbons RD, O’Neill HJ (1985) Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem 31(8):1278–1282
Phillips M (1997) Method for the collection and assay of volatile organic compounds in breath. Anal Biochem 247:272–278
Phillips M, Erickson GA, Sabas M, Smith JP, Greenberg J (1995) Volatile organic compounds in the breath of patients with schizophrenia. J Clin Pathol 48:466–469
Karl T, Prazeller P, Mayr D, Jordan A, Rieder J, Fall R, Lindinger W (2001) Human breath isoprene and its relation to blood cholesterol levels: new measurements and modeling. J Appl Physiol 91:762–770
Westhoff M, Litterst P, Freitag L, Urfer W, Bader S, Baumbach JI (2009) Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 64:744–774
Pleil JD, Lindstrom AB (1997) Exhaled human breath measurement method for assessing exposure to halogenated volatile organic compounds. Clin Chem 43:723–730
Amann A, Smith D (2005) Breath analysis for clinical diagnosis and therapeutic monitoring. World Scientific Publishing, 5 Toh Tuck Link, Singapore
Belda Iniesta C, de Castro J, Carpeño CJA, Moreno V, Casado Sáenz E, Feliu J, Sereno M, García Río F, Barriuso J, González Barón M (2007) New screening method for lung cancer by detecting volatile organic compounds in breath. Clin Transl Oncol 9:364–368
Friedrich MJ (2009) Scientists seek to sniff out diseases: electronic “noses” may someday be diagnostic tools. JAMA 301:585–586
Sobin LH, Witterkind C (2002) TNM classification of malignant tumours. International Union Against Cancer, 6th edn. Wiley-Liss, New York
Dragonieri S, Schot R, Mertens JA, Le Cessie S, Gauw SA, Spanevello A, Resta O, Willard NP, Vink TJ, Rabe KF, Bel EH, Sterk PJ (2007) An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol 120(4):856–862
Bruno P, Caselli M, de Gennaro G, Iacobellis S, Tutino M (2008) Monitoring of volatile organic compounds in non-residential indoor environments. Indoor Air 18:150–156
Zupan J, Gasteiger J (1999) Neural networks in chemistry and drug design, 2nd edn. Wiley-VCH, Weinheim
Zupan J, Novi M, Ruisánchez I (1997) Kohonen and counterpropagation artificial neural networks in analytical chemistry. Chemom Intell Lab Syst 38:1–23
Kohonen T (1988) Self-organization and associative memory. Springer, Berlin
Chase RE (2001) Properties and manufacture of TedlarR polyvinyl fluoride film VERL. Ford Research Laboratory ERC Technical Report Issued
Steeghs MML, Cristescu SM, Munnik P, Zanen P, Harren FJM (2007) The suitability of Tedlar bags for breath sampling in medical diagnostic research. Physiol Meas 28:73–84
Trabue SL, Anhalt J, Zahn JA (2006) Bias of Tedlar bags in the measurement of agricultural odorants. J Environ Qual 35:1668–1677
Gross P (1984) Biologic activity of epsilon-caprolactam. Crit Rev Toxicol 13:205–216
Landi MT, Consonni D, Rotunno M, Bergen AW, Goldstein AM (2008) Environment and Genetics in Lung Cancer Etiology (EAGLE) Study: an integrative population-based case–control study of lung cancer. BMC Public Health 8:203
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Gennaro, G., Dragonieri, S., Longobardi, F. et al. Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure. Anal Bioanal Chem 398, 3043–3050 (2010). https://doi.org/10.1007/s00216-010-4238-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-4238-y